{
  "id": 6763213,
  "title": "Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use",
  "url": "https://urgent.news/2026/09/11/karyopharm-pushes-off-debt-payment-amgen-eyes-broader-imdelltra-use",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-11T13:37:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/imdelltra-bridgebio-oncology-evommune-encoded-tectora/830056/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Karyopharm bought an extra month to negotiate with creditors or pursue a deal. Elsewhere, BridgeBio Pharma’s oncology spinout shook up its development plans and a brain-focused gene therapy startup banked $275 million.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}